ClinicalTrials.gov
public full text
Public Domain
Oxytocin to Decrease Blood Loss During Cesarean Section
The goal of this study is to determine the best dose of a drug called oxytocin, that is usually used to stop bleeding during a delivery, when used during a cesarean delivery. It will be administered during cesarean section in order to decrease the amount blood loss. The investigators are proposing to have 3 groups of subjects each given a different safe dose of oxytocin and then to assess the effectiveness of each regimens on the amount blood lost during cesarean sections.This will let use know which is the best lowest dose needed.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Oxytocin i.m./i.v. Versus Carbetocin i.v. in Elective Cesarean Sections#856796
- Cardiac Effects of Oxytocin Administrated During Cesarean Section, Signs of Myocardial Ischemia#870849
- Is Oxytocin Given During Surgical Procedure for Abortion Before 12 Weeks of Pregnancy Useful?#1088675
- Ergot and Oxytocin During Cesarean Delivery Following Failure to Progress in Labour#833468
- Intrapartum Oxytocin and Maternal Outcomes Following Vaginal and Unscheduled Cesarean Delivery#390892
Record · ID 1336775
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive